MENU

RARE Ultragenyx Pharmaceutical Forecast, Technical & Fundamental Analysis

a developer of therapeutics for rare diseases

Industry Biotechnology
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RARE is expected to report earnings to fall 3.57% to -135 cents per share on February 13

Ultragenyx Pharmaceutical RARE Stock Earnings Reports
Q4'24
Est.
$-1.35
Q3'24
Beat
by $0.08
Q2'24
Beat
by $0.14
Q1'24
Missed
by $0.28
Q4'23
Beat
by $0.18
The last earnings report on November 05 showed earnings per share of -139 cents, beating the estimate of -148 cents. With 354.82K shares outstanding, the current market capitalization sits at 4.15B.
A.I. Advisor
published General Information

General Information

a developer of therapeutics for rare diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
60 Leveroni Court
Phone
+1 415 483-8800
Employees
1276
Web
https://www.ultragenyx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

RARE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RARE has been loosely correlated with CRNX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RARE jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RARE
1D Price
Change %
RARE100%
-0.99%
CRNX - RARE
44%
Loosely correlated
+1.35%
DNLI - RARE
44%
Loosely correlated
-0.30%
PGEN - RARE
42%
Loosely correlated
+2.46%
ROIV - RARE
42%
Loosely correlated
+0.41%
ARWR - RARE
41%
Loosely correlated
-0.45%
More